On October 


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Theseus Pharmaceuticals, Inc.



/s/ Bradford D. Dahms


Name: Bradford D. Dahms


Title: Chief Financial Officer

Date: October 27, 2021

makes a similar move, sign up!

Auto Refresh